Effectiveness and Tolerability of Febuxostat vs Allopurinol in patients with Chronic Kidney Disease (CKD) on Conservative Therapy
<p>Uric Acid appears to be one of the most important prognostic markers and one of the principal risk factors for cardiovascular diseases. The aim of our study was to assess three groups of patients: a first group treated with Allopurinol (AL), a second ...
Saved in:
Main Authors: | Filomena Panza (Author), Chiara Ralli (Author), Ennio Duranti (Author) |
---|---|
Format: | Book |
Published: |
Archives of Renal Diseases and Management - Peertechz Publications,
2017-06-19.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Short-Term Effects of Pre/Probiotics on P-Cresol and Indoxyl-Sulphate Serum Concentrations During the Various Stages of Chronic Kidney Disease
by: Filomena Panza, et al.
Published: (2017) -
The potential renoprotection of xanthine oxidase inhibitors: Febuxostat versus allopurinol
by: Dong-Ryeol Ryu
Published: (2017) -
Cardiovascular safety of febuxostat and allopurinol in patients with gout: A meta-analysis
by: Xudong Guan, et al.
Published: (2022) -
Febuxostat for Hyperuricemia in Patients with Advanced Chronic Kidney Disease
by: Tetsu Akimoto, et al.
Published: (2014) -
Febuxostat for Hyperuricemia in Patients with Advanced Chronic Kidney Disease
by: Tetsu Akimoto, et al.
Published: (2014)